At a glance
ClinicalIndex Comparison RecordN/ACompleted· 24 enrolled
Drug / intervention
ARGOS-SC suprachoroidal pressure sensordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Open-label, Single Arm, Multicenter Clinical Investigation to Assess the Safety and Performance of the ARGOS-SC Suprachoroidal Pressure Sensor System in Patients With Glaucoma Undergoing Non-penetrating Glaucoma Surgery
In Brief
A clinical study evaluating ARGOS-SC suprachoroidal pressure sensor for Glaucoma and Open Angle Glaucoma. Completed, enrolled 24 participants across 5 sites in 2 countries.
Detailed Summary
The purpose of this study is to evaluate both the safety and feasibility of the surgical implantation of the ARGOS-SC implant during non-penetrating glaucoma surgery and the safety and usability of the ARGOS-SC implant and system in the year following the implantation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma, Open Angle Glaucoma
CountriesGermany, Switzerland
CollaboratorsCRO Dr. med Kottmann GmbH & Co. KG
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartNov 2018
First PostedNov 2018
Primary CompletionFeb 2021
TodayJul 2026
First PostedNov 28, 2018
Enrollment StartNov 19, 2018
Primary CompletionFeb 18, 2021
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 7.6 years ago
Interventions
ARGOS-SC suprachoroidal pressure sensordevice
The sensor device is intended to be permanently implanted suprachoroidal in the human eye during non-penetrating glaucoma surgery.